Saitama, Japan

Kenichi Nakazawa

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Meiji Co., Ltd.. Active years: 2012-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenichi Nakazawa. Retrieved from https://idiyas.com/inventor/kenichi-nakazawa-5vrl48bn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kenichi Nakazawa: Innovator in Rotavirus Infection Prevention

Introduction

Kenichi Nakazawa is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of medical science, particularly in the development of compositions aimed at preventing rotavirus infections. With a total of 2 patents to his name, Nakazawa's work is recognized for its innovative approach to addressing viral infections.

Latest Patents

One of Nakazawa's latest patents focuses on compositions against rotavirus infection and the processes for producing these compositions. The invention reveals that microfiltration retentates of whey, along with products obtained through centrifugation and/or ammonium sulfate precipitation, possess the ability to inhibit rotavirus infection. In one embodiment, the invention provides a method for preventing rotavirus infection by administering a composition that includes a whey cream serum obtained through centrifugation or a dehydrated product thereof. Notably, the antiviral activity of this composition is retained even after heat treatment.

Career Highlights

Kenichi Nakazawa has established himself as a key figure in his field through his innovative research and development efforts. His work at Meiji Co., Ltd. has allowed him to explore and implement groundbreaking solutions to combat viral infections. His dedication to scientific advancement is evident in his patent filings and ongoing research.

Collaborations

Throughout his career, Nakazawa has collaborated with esteemed colleagues, including Yoshihiro Kanamaru and Yoshitaka Nakamura. These partnerships have contributed to the success of his research and the development of effective antiviral compositions.

Conclusion

Kenichi Nakazawa's contributions to the field of medical science, particularly in the area of rotavirus infection prevention, highlight his innovative spirit and dedication to improving public health. His patents and collaborative efforts continue to pave the way for advancements in antiviral treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…